Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hong Kong Drug Regulators To Step Up Inspections To Improve Drug Safety

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Hong Kong regulators may step up inspections of drug manufacturing facilities outside the former British enclave following a series of recommendations in December to improve drug safety

You may also be interested in...



Hong Kong Industry Works With Regulator To Ensure Open Market Stays Open

Major changes are afoot in Hong Kong’s drug approval and regulatory process with safety a prime focus following a series of reforms implemented last year in response to six deaths from spurious generic drugs in 2009.

ASEAN Makes Slow But Steady Progress Toward Harmonization Of Pharmaceutical Regulations

SHANGHAI - The Association of Southeast Asian Nations is slated to implement common technical documents starting this year as part of "harmonized" pharmaceutical regulations in the region, which could benefit consumers by 2010

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

SC074015

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel